I am happy to share our new article in
@BloodJournal
. Acute myelopathy is a rare but devastating complication of CAR T-cell therapy: authors.elsevier.com/a/1k5wW1UYwn...
#CART #CellTherapy #Lymphoma #All
@BloodJournal
. Acute myelopathy is a rare but devastating complication of CAR T-cell therapy: authors.elsevier.com/a/1k5wW1UYwn...
#CART #CellTherapy #Lymphoma #All
December 4, 2024 at 4:26 PM
I am happy to share our new article in
@BloodJournal
. Acute myelopathy is a rare but devastating complication of CAR T-cell therapy: authors.elsevier.com/a/1k5wW1UYwn...
#CART #CellTherapy #Lymphoma #All
@BloodJournal
. Acute myelopathy is a rare but devastating complication of CAR T-cell therapy: authors.elsevier.com/a/1k5wW1UYwn...
#CART #CellTherapy #Lymphoma #All
How's your week starting out? This smiling zebrafish neutrophil we imaged years ago should make it better!
@BloodJournal
ashpublications.org/blood/issue/...
#immunology #science #development
@BloodJournal
ashpublications.org/blood/issue/...
#immunology #science #development
April 15, 2025 at 3:20 PM
How's your week starting out? This smiling zebrafish neutrophil we imaged years ago should make it better!
@BloodJournal
ashpublications.org/blood/issue/...
#immunology #science #development
@BloodJournal
ashpublications.org/blood/issue/...
#immunology #science #development
New issue of Blood out now featuring: Molecular modeling of Waldenström macroglobulinemia, Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria, and more. #Blood #BloodJournal #NewIssue #Hemesky ashpublications.org/blood/issue/...
December 18, 2025 at 8:39 PM
New issue of Blood out now featuring: Molecular modeling of Waldenström macroglobulinemia, Rbm38 binds Fech pre-mRNA to prevent anemia and porphyria, and more. #Blood #BloodJournal #NewIssue #Hemesky ashpublications.org/blood/issue/...
Today marks the 80th anniversary of Blood Journal. We're looking forward to commemorating this milestone throughout 2026 and hope you enjoy the new issue out now. ashpublications.org/blood/issue/... Happy new year! #Anniversary #BloodJournal
January 1, 2026 at 7:28 PM
Today marks the 80th anniversary of Blood Journal. We're looking forward to commemorating this milestone throughout 2026 and hope you enjoy the new issue out now. ashpublications.org/blood/issue/... Happy new year! #Anniversary #BloodJournal
Guidelines for determination of the number of prior lines of therapy in multiple myeloma [Aug 13, 2015] @VincentRK , Richardson, San Miguel @BloodJournal ow.ly/KF4y30qyGWj #mmsm #ctsm #ClinicalTrials
March 3, 2025 at 2:58 PM
Guidelines for determination of the number of prior lines of therapy in multiple myeloma [Aug 13, 2015] @VincentRK , Richardson, San Miguel @BloodJournal ow.ly/KF4y30qyGWj #mmsm #ctsm #ClinicalTrials
New issue of Blood out now featuring Proteomic subtypes and aging patterns of AML, Challenging functional high-risk MM, and more. ashpublications.org/blood/issue/... #BloodJournal #Hemesky
November 28, 2025 at 9:05 PM
New issue of Blood out now featuring Proteomic subtypes and aging patterns of AML, Challenging functional high-risk MM, and more. ashpublications.org/blood/issue/... #BloodJournal #Hemesky
#ASH Roadmap to #EDI in Hematology #RCTs
📍Harmonized terminology
📍Patient engagement
📍Awareness of #enrolment biases
📍Broader eligibility criteria
📍Decentralized design
📍⬆️pt access to RCT info
📍⬆️community physician involvem’t @bloodjournal
📍Harmonized terminology
📍Patient engagement
📍Awareness of #enrolment biases
📍Broader eligibility criteria
📍Decentralized design
📍⬆️pt access to RCT info
📍⬆️community physician involvem’t @bloodjournal
December 20, 2024 at 10:03 PM
#ASH Roadmap to #EDI in Hematology #RCTs
📍Harmonized terminology
📍Patient engagement
📍Awareness of #enrolment biases
📍Broader eligibility criteria
📍Decentralized design
📍⬆️pt access to RCT info
📍⬆️community physician involvem’t @bloodjournal
📍Harmonized terminology
📍Patient engagement
📍Awareness of #enrolment biases
📍Broader eligibility criteria
📍Decentralized design
📍⬆️pt access to RCT info
📍⬆️community physician involvem’t @bloodjournal
MECOM promotes malignant stem cell–like states in aggressive AMLs by directly repressing prodifferentiation gene regulatory programs. Read the plenary paper in Blood: buff.ly/MUfiZMN #BloodJournal #PlenaryPaper #AML
December 24, 2025 at 1:44 PM
MECOM promotes malignant stem cell–like states in aggressive AMLs by directly repressing prodifferentiation gene regulatory programs. Read the plenary paper in Blood: buff.ly/MUfiZMN #BloodJournal #PlenaryPaper #AML
Enticing data for axi-cel in high risk upfront DLBCL in ZUMA-12 3 year followup @BloodJournal
75% 3-year progression free survival
ashpublications.org/blood/articl...
Randomised ZUMA-23 data eagerly awaited
#lymsm #lymphoma
75% 3-year progression free survival
ashpublications.org/blood/articl...
Randomised ZUMA-23 data eagerly awaited
#lymsm #lymphoma
February 15, 2025 at 5:35 AM
Enticing data for axi-cel in high risk upfront DLBCL in ZUMA-12 3 year followup @BloodJournal
75% 3-year progression free survival
ashpublications.org/blood/articl...
Randomised ZUMA-23 data eagerly awaited
#lymsm #lymphoma
75% 3-year progression free survival
ashpublications.org/blood/articl...
Randomised ZUMA-23 data eagerly awaited
#lymsm #lymphoma
Landmark revisit
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Macrophages pull together angiogenic sprouts to fuse!😍
#BloodJournal 2010
ashpublications.org/blood/articl...
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Macrophages pull together angiogenic sprouts to fuse!😍
#BloodJournal 2010
ashpublications.org/blood/articl...
April 26, 2024 at 7:23 PM
Landmark revisit
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Macrophages pull together angiogenic sprouts to fuse!😍
#BloodJournal 2010
ashpublications.org/blood/articl...
Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction
Macrophages pull together angiogenic sprouts to fuse!😍
#BloodJournal 2010
ashpublications.org/blood/articl...
New Blood issue out now featuring: Refitting fitness in CLL, Enhancing fibrinolysis in obesity, and more. ashpublications.org/blood/issue/... #Blood #BloodJournal #NewIssue #Hemesky
November 14, 2025 at 3:25 PM
New Blood issue out now featuring: Refitting fitness in CLL, Enhancing fibrinolysis in obesity, and more. ashpublications.org/blood/issue/... #Blood #BloodJournal #NewIssue #Hemesky
Thank you for the copies of the paper on the UK Infected Blood Inquiry that was published in @BloodJournal. It is interesting to see the section on lessons learned. Despite the @bloodinquiry, the UK continues to use cryo and FFP without viral inactivation. #hemophilia
April 10, 2025 at 8:15 PM
Thank you for the copies of the paper on the UK Infected Blood Inquiry that was published in @BloodJournal. It is interesting to see the section on lessons learned. Despite the @bloodinquiry, the UK continues to use cryo and FFP without viral inactivation. #hemophilia
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation [Sep 19, 2024] @KLChohan et al. @BloodJournal
ashpublications.org/blood/articl... #lymphoidneoplasia #wmsm
ashpublications.org/blood/articl... #lymphoidneoplasia #wmsm
May 19, 2025 at 7:05 PM
Multiomics analysis of IgM monoclonal gammopathies reveals epigenetic influence on oncogenesis via DNA methylation [Sep 19, 2024] @KLChohan et al. @BloodJournal
ashpublications.org/blood/articl... #lymphoidneoplasia #wmsm
ashpublications.org/blood/articl... #lymphoidneoplasia #wmsm
"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel." Read the special report in Blood: ow.ly/y9uP50YCt3X #AML #BloodJournal #SpecialReport
April 6, 2026 at 9:01 PM
"Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel." Read the special report in Blood: ow.ly/y9uP50YCt3X #AML #BloodJournal #SpecialReport
Windy, good day for a run with Beef (that's my dog), #BloodJournal, and the latest Review Series podcast episode.
#hemostasis #hematology @bloodjournal.bsky.social
open.spotify.com/episode/7fNe...
#hemostasis #hematology @bloodjournal.bsky.social
open.spotify.com/episode/7fNe...
February 17, 2025 at 6:31 PM
Windy, good day for a run with Beef (that's my dog), #BloodJournal, and the latest Review Series podcast episode.
#hemostasis #hematology @bloodjournal.bsky.social
open.spotify.com/episode/7fNe...
#hemostasis #hematology @bloodjournal.bsky.social
open.spotify.com/episode/7fNe...
New issue of #Blood out now featuring Hematopoietic transplantation for PNP deficiency, The telomeric puzzle in TP53-mutant myeloid neoplasms, and more. ashpublications.org/blood/issue/... #BloodJournal #NewIssue
January 8, 2026 at 6:44 PM
New issue of #Blood out now featuring Hematopoietic transplantation for PNP deficiency, The telomeric puzzle in TP53-mutant myeloid neoplasms, and more. ashpublications.org/blood/issue/... #BloodJournal #NewIssue
Off-the-shelf bispecific CD133-CD19 CAR-iNKT cells eradicate CAR antigen–high and –low medullary and leptomeningeal KMT2Ar ALL. Read in Blood: buff.ly/HIlsUq7 #ALL #BloodJournal
January 12, 2026 at 5:15 PM
Off-the-shelf bispecific CD133-CD19 CAR-iNKT cells eradicate CAR antigen–high and –low medullary and leptomeningeal KMT2Ar ALL. Read in Blood: buff.ly/HIlsUq7 #ALL #BloodJournal
New issue of Blood out now featuring: Luminal hepcidin targets intestinal DMT1, Improving MM outcomes with bispecific antibody combinations, Neutrophils fine-tune the NET effects of activation, and more. ashpublications.org/blood/issue/... #Blood #BloodJournal
December 11, 2025 at 6:13 PM
New issue of Blood out now featuring: Luminal hepcidin targets intestinal DMT1, Improving MM outcomes with bispecific antibody combinations, Neutrophils fine-tune the NET effects of activation, and more. ashpublications.org/blood/issue/... #Blood #BloodJournal
New issue of Blood out now! Featuring Tuning mitochondrial fate to disarm leukemic stem cells, Pretransplant promise for PD-1 in Hodgkin lymphoma, Hemophagocytic lymphohistiocytosis in adults, and more. Explore here: ashpublications.org/blood/issue/... #BloodJournal
March 5, 2026 at 4:41 PM
New issue of Blood out now! Featuring Tuning mitochondrial fate to disarm leukemic stem cells, Pretransplant promise for PD-1 in Hodgkin lymphoma, Hemophagocytic lymphohistiocytosis in adults, and more. Explore here: ashpublications.org/blood/issue/... #BloodJournal
Out in @bloodjournal during #ASH24 - cool work by @freemanlciaraMD @DrFredLocke et al looking at #MMsm CAR-T in myeloma:
MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T.
ashpublications.org/blood/articl...
MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T.
ashpublications.org/blood/articl...
December 13, 2024 at 6:49 PM
Out in @bloodjournal during #ASH24 - cool work by @freemanlciaraMD @DrFredLocke et al looking at #MMsm CAR-T in myeloma:
MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T.
ashpublications.org/blood/articl...
MTV (by PET-CT), sBCMA, BMPC don't always correlate. Some MTV-high but sBCMA-low pts exist - may not respond durably to BCMA CAR-T.
ashpublications.org/blood/articl...
Einen #Tumor von verschiedenen Seiten attackieren: Das haben Dr. Gottschlich und Prof. Kobold vom LMU Klinikum im Labor gemacht. Es geht dabei um das Hodgkin-Syndrom, eine Form des Lymphdrüsenkrebs. Die Studie wurde im @BloodJournal veröffent...
weiterlesen
weiterlesen
April 4, 2025 at 8:54 AM
Einen #Tumor von verschiedenen Seiten attackieren: Das haben Dr. Gottschlich und Prof. Kobold vom LMU Klinikum im Labor gemacht. Es geht dabei um das Hodgkin-Syndrom, eine Form des Lymphdrüsenkrebs. Die Studie wurde im @BloodJournal veröffent...
weiterlesen
weiterlesen
Thrilled to see our effort on behalf of @ic_MDS group out in @BloodJournal about reducing clinical trial eligibility barriers for our MDS patients. Commentary by Lionel Ades on ‘ releasing the brake’ on eligibility criteria. @Dr_AmerZeidan #mdssm ashpublications.org/blood/article/…
March 28, 2025 at 3:25 PM
Thrilled to see our effort on behalf of @ic_MDS group out in @BloodJournal about reducing clinical trial eligibility barriers for our MDS patients. Commentary by Lionel Ades on ‘ releasing the brake’ on eligibility criteria. @Dr_AmerZeidan #mdssm ashpublications.org/blood/article/…
Uma Borate, MD, MS published "Reducing clinical trial eligibility barriers for patients with #MDS: an icMDS position statement" @BloodJournal!
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
April 8, 2025 at 5:06 PM
Uma Borate, MD, MS published "Reducing clinical trial eligibility barriers for patients with #MDS: an icMDS position statement" @BloodJournal!
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
🔗https://pubmed.ncbi.nlm.nih.gov/40146152/
Check out the new format of the #BloodPodcast! Short conversation between our podcast editors and senior authors of recently published work in the #BloodJournal.
🎙️ Just published a new episode of Blood Podcast: Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions. Have a listen:
Bispecific Antibodies in Aggressive B-Cell Lymphoma: Real-World Insights and Future Directions
In this week's episode, Blood editor Dr. Laura Michaelis interviews...
bloodpodcast.transistor.fm
November 7, 2025 at 3:17 PM
Check out the new format of the #BloodPodcast! Short conversation between our podcast editors and senior authors of recently published work in the #BloodJournal.
Editor-in-Chief of Blood, Dr. Andrew Roberts, speaking at #NDLR2026 for today's meet-the-editor session. Thanks to all who joined him in Adelaide. #BloodJournal
March 4, 2026 at 3:16 PM
Editor-in-Chief of Blood, Dr. Andrew Roberts, speaking at #NDLR2026 for today's meet-the-editor session. Thanks to all who joined him in Adelaide. #BloodJournal